Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy.
Turiello R, Capone M, Giannarelli D, Morretta E, Monti MC, Madonna G, Mallardo D, Festino L, Azzaro R, Levesque MP, Imhof L, Weide B, Amaral T, Chevrier M, Sucker A, Rutkowski P, Schadendorf D, Lebbe C, Luke JJ, Wistuba-Hamprecht K, Dummer R, Pinto A, Morello S, Ascierto PA.
Turiello R, et al. Among authors: morretta e.
J Immunother Cancer. 2020 Dec;8(2):e001689. doi: 10.1136/jitc-2020-001689.
J Immunother Cancer. 2020.
PMID: 33361405
Free PMC article.